Literature DB >> 638318

Mechanism of action of hydralazine and ISF 2123 on arterial smooth muscle [proceedings].

M Worcel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638318      PMCID: PMC1668212     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  8 in total

1.  Studies on hydralazine; evidence for a peripheral site of action.

Authors:  A STUNKARD; L WERTHEIMER; W REDISCH
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

2.  Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension.

Authors:  J H MOYER
Journal:  AMA Arch Intern Med       Date:  1953-04

3.  Renal hyperemia induced in man by a new phthalazine derivative.

Authors:  F C REUBI
Journal:  Proc Soc Exp Biol Med       Date:  1950-01

Review 4.  Medical intelligence drug therapy.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1976-08-05       Impact factor: 91.245

Review 5.  [Pharmacological and biochemical effects of hydralazine and dihydralazine].

Authors:  P A van Zwieten
Journal:  Arzneimittelforschung       Date:  1968-01

6.  Characteristics and clinical effects of ISF 2123, a new antihypertensive agent.

Authors:  R Pellegrini; G Abbondati
Journal:  Farmaco Prat       Date:  1977-01

7.  Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut.

Authors:  G Burnstock; G Campbell; D Satchell; A Smythe
Journal:  Br J Pharmacol       Date:  1970-12       Impact factor: 8.739

8.  Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide.

Authors:  G Burnstock; B Dumsday; A Smythe
Journal:  Br J Pharmacol       Date:  1972-03       Impact factor: 8.739

  8 in total
  1 in total

1.  Hypothermic effect of hydralazine in rodents.

Authors:  H Rigter; J C Crabbe; E Schönbaum
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.